Advertisement
The drug Rubraca (rucaparib) has been granted accelerated approval by the U.S. Food and Drug Administration to treat advanced ovarian cancer.

FDA Grants Fast-Track Approval to Ovarian Cancer Drug

0
Rubraca's use is specific to women with deleterious BRCA mutations
Follow-up magnetic resonance imaging after a mid-pregnancy ultrasound could help improve diagnosis of possible fetal brain abnormalities

MRI Ups Diagnostic Accuracy of Fetal Brain Abnormalities

0
Researchers recommend its use mid-pregnancy if ultrasound picks up potential anomaly
Pokémon Go provided a slight

No Long-Term Increase in Exercise Levels for Pokémon Go

0
Study found the virtual reality game got adults moving -- but only for a while
After actress Angelina Jolie's 2013 New York Times editorial that announced her preventive double mastectomy

BRCA Testing, Not Mastectomies, Up After Angelina Jolie Editorial

0
More women tested for the BRCA genes but no corresponding increase in mastectomy rates
The presence of a non-Lactobacillus-dominated microbiota in a receptive endometrium is associated with poor reproductive outcomes for women undergoing in vitro fertilization

Endometrial Microbiota May Be Linked to Success of IVF

0
Presence of a non-Lactobacillus-dominated microbiota linked to poor reproductive outcomes
Zika's ability to damage the infant brain may be even more far-reaching and insidious than previously thought

Zika-Related Birth Defects More Extensive Than Thought

0
Studies found greater prevalence than believed, more neurological problems appearing months after birth
Repeated or lengthy use -- longer than three hours -- of general anesthetic and sedation drugs may harm the developing brains of fetuses and children younger than 3 years old

FDA Issues New Safety Info on Use of Anesthesia

0
New information addresses anesthesia use in pregnant women and young children
Preeclampsia is associated with increased risk of maternal retinal disease

Preeclampsia Linked to Risk of Maternal Retinal Disease

0
Risk was higher for severe and early-onset preeclampsia versus mild or late-onset disease
For patients with triple-negative breast cancer

Triple-Negative Breast Cancer Subtype Chemosensitive

0
Patients with functionally BRCA-D tumors have notably better survival with standard-of-care chemo
For women with a singleton pregnancy planning a repeat cesarean delivery

Universal Group B Streptococci Screening Not Cost-Effective

0
Screening before repeat C-section may become cost-effective in populations with high GBS prevalence